CODEXIS (4QK.SG) (4QK STU) stock market data APIs
€2.4342
0(0%)
as of July 10, 2025
Try our APIs with
free plan!
CODEXIS (4QK.SG) Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for 4QK.SG.
Prev. Close
2.4342
Open
2.4342
High
2.4342
Low
2.4342
52 wk Range
1.732-5.665
Market Cap
1 822 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CODEXIS (4QK.SG) data using free add-ons & libraries
Get CODEXIS (4QK.SG) Fundamental Data
CODEXIS (4QK.SG) Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CODEXIS (4QK.SG) News
New
Codexis Announces Byron Dorgan to Retire from Board of Directors
Codexis, Inc. REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, t...
Arcutis Biotherapeutics (ARQT) Moves 10.8% Higher: Will This Strength Last?
Arcutis Biotherapeutics, Inc. (ARQT) shares soared 10.8% in the last trading session to close at $16.60. The move was backed by solid volume with far more shares changing hands than in a normal sessio...
Codexis Appoints Cynthia Collins to Board of Directors
Codexis, Inc. REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, t...
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
Codexis, Inc. Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
